예림화학

비상장계속사업자

YERIM CHEMICAL

전용진

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

예림화학

Business Reg. No. 5088701576 · CEO 전용진

I.Investment Overview

Target예림화학 (5088701576)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명예림화학
영문명YERIM CHEMICAL
대표자전용진
사업자등록번호5088701576
법인등록번호1348110526957
설립일2019.12.01
종업원수48명

V.Workforce

48

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW3722021361.82022284.32023276.92024306.52025
영업이익100M KRW5202127.720221.82023-1.92024-0.32025
순이익100M KRW2.1202120.92022-4.32023-8.52024-52025
Item20252024202320222021
자산총계212.8억원200억원207.1억원231.7억원217.5억원
부채총계190.2억원172.4억원170.6억원191억원197.6억원
자본총계22.5억원27.6억원36.5억원40.8억원19.9억원
매출액306.5억원276.9억원284.3억원361.8억원372억원
영업이익-2,686만원-1.9억원1.8억원27.7억원5억원
순이익-5억원-8.5억원-4.3억원20.9억원2.1억원

VII.Financial Ratios

FY2025 basis

-0.09%

영업이익률

-1.64%

순이익률

-2.36%

ROA

-22.3%

ROE

844.18%

부채비율

10.59%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

예림화학 투심보고서 | Alpha Lenz